Renovus Capital Partners Invests In Thomas J. Paul, A Leading Provider Of Market Access Marketing Support For Healthcare Customers And Marketing Communications Services For Consumer Brands
Round Type
Funding Round
PhiladelphiaBiotechnologyHealth CareInvestors
Description
Renovus Capital Partners ("Renovus") is pleased to announce a majority investment in Thomas J Paul, Inc. ("TJP" or "the Company"). Based in Rydal, PA, TJP serves some of the largest global pharmaceutical companies in the highly specialized areas of market access, payer marketing, patient access and affordability as well as consumer packaged goods clients. The Company designs, implements and manages sales and marketing campaigns that (1) introduce new drugs to insurance providers to achieve non-disadvantaged formulary status and (2) educate healthcare providers and patients on obtaining access to therapy and available financial support options, including copay support for high-cost therapies.
Quick answer
Thomas J. Paul raised an undisclosed amount in a Funding Round round, dated January 16, 2023. Investors: Renovus Capital Partners. Thomas J. Paul is based in Philadelphia, Pennsylvania, United States.
- How much did Thomas J. Paul raise?
- Thomas J. Paul raised an undisclosed amount in a Funding Round round on January 16, 2023.
- Who invested in Thomas J. Paul?
- Renovus Capital Partners is named as investors in this round.
- What does Thomas J. Paul do?
- TJP is a leading healthcare marketing communications and sales training consultant serving several large global pharmaceutical companies in the highly specialized area of payer marketing as well as access and..
- Where is Thomas J. Paul based and how big is it?
- Thomas J. Paul is based in Philadelphia, Pennsylvania, United States.
- Who are the decision-makers at Thomas J. Paul?
- Fundz holds 2 contacts at Thomas J. Paul, including the Associate Director of Project Management. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Thomas J. Paul that raised within 45 days of this round, from Fundz verified event records.
- Corista raised $13M on March 1, 2023.
- Wilson Wolf Manufacturing raised an undisclosed amount on March 1, 2023.
- Chroma Medicine raised $135M (Series B) on March 1, 2023.
- SigTuple raised $4.5M (Seed) on March 1, 2023.
- Aprea Therapeutics raised an undisclosed amount (Funding Round) on February 28, 2023.
- Tessera Defense & Homeland Security Inc. raised $1.5M (Seed) on February 27, 2023.
Who to call at Thomas J. Paul, and when
A new round usually means Thomas J. Paul is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Thomas J. Paul raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Thomas J. Paul, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Thomas J. Paul. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Thomas J. Paul raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Thomas J. Paul raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.